Register/ Login   
Submit Mobile RSS Java Script Feed  
Home Blogs Spotlight Videos Movies Cartoon Photos Submit Media Space  Feed Directory 





Profile :

Daniel has not filled out a profile yet.

Content Created :

Blogs Posted :9
Articles Posted:0
Videos Uploaded :0
Albums Uploaded :0

Member Since: 13-12-2007
Daniel has no friends.
Previous
    
Next
Eli Lilly STALLING on ZYPREXA Payouts
Published on May 9th, 2008 In Uncategorized, Blogging, News |  Views 2842

Lilly"s credibility over their continuous PR on how they are going to pay out $1.2 billion in Zyprexa damages.Many claimants are being stonewalled!

Eli Lilly makes billions on diabetes treatment and also gets $4.2 billion a year in sales of their biggest cash cow Zyprexa which has been scandalized as *causing* diabetes as a major side effect. Not fair! Zyprexa off label promotion scandal is all over the news now.
Lilly drug reps are alleged to have called their marketing ploy,"Viva zyprexa".

 

Eli Lilly zyprexa cost me over $250.00 a month supply out of my own pocket X 4 years and has up to ten times the risk (over non users) of causing diabetes and severe weight gain. In 2004, the American Diabetes Association found that Zyprexa was more likely to cause diabetes than many other antipsychotic drugs.

untitled-1.jpg ZYPREXA DEATH picture by DannyHaszard

A big hurdle with the Zyprexa issue is Lilly"s credibility over their continuous PR on how they are going to pay out $1.2 billion in damages.As long as they keep up this rhetoric and don"t actually pay the issue won"t go away. They need to think about ‘putting their money where their mouth is".

 

Daniel Haszard www.zyprexa-victims.com

 

Don"t shoot the

messengers

  Share      Print


Comments are closed.


Recent Posts





     

Madurai Sambavam...

Thiruvannamalai...

Poo...


Odi polama...

Thenavattu...

A AA E EE...

Mika Next Hot Musi ...

Perumal Trailer ...

A AA E EE Shooting ...


King Teaser Traile ...

Vivek Inaugurates ...

Ennai Theriyuma Tr ...
     


About | Content providers | Support | Beta feedback | Report abuse | Contact us | Careers | FAQ